Merck & Company Inc (MRK)vsMettler-Toledo International Inc (MTD)
MRK
Merck & Company Inc
$120.79
-1.42%
HEALTHCARE · Cap: $285.64B
MTD
Mettler-Toledo International Inc
$1,154.33
-2.22%
HEALTHCARE · Cap: $22.86B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 1508% more annual revenue ($65.77B vs $4.09B). MTD leads profitability with a 21.4% profit margin vs 13.6%. MTD appears more attractively valued with a PEG of 2.37. MTD earns a higher WallStSmart Score of 62/100 (C+).
MRK
Hold50
out of 100
Grade: D+
MTD
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-49.3%
Fair Value
$80.88
Current Price
$120.79
$39.91 premium
Intrinsic value data unavailable for MTD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Generating 2.9B in free cash flow
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 30 in profit
Keeps 21 of every $100 in revenue as profit
Strong operational efficiency at 23.3%
Areas to Watch
Premium valuation, high expectations priced in
4.9% revenue growth
Elevated debt levels
Weak financial health signals
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : MTD
The strongest argument for MTD centers on Debt/Equity, Altman Z-Score, Return on Equity. Profitability is solid with margins at 21.4% and operating margin at 23.3%.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Debt/Equity.
Bear Case : MTD
The primary concerns for MTD are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
MRK profiles as a value stock while MTD is a mature play — different risk/reward profiles.
MTD carries more volatility with a beta of 1.26 — expect wider price swings.
MTD is growing revenue faster at 7.2% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
MTD scores higher overall (62/100 vs 50/100), backed by strong 21.4% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Mettler-Toledo International Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Mettler Toledo (NYSE: MTD) is a multinational manufacturer of scales and analytical instruments. It is the largest provider of weighing instruments for use in laboratory, industrial, and food retailing applications. The company also provides various analytical instruments, process analytics instruments, and end-of-line inspection systems.
Visit Website →Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?